CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Santen Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Santen Pharmaceutical Co Ltd
3-9-19, Shimo-Shinjo, Higashiyodogawa-ku
Phone: +81 676648621p:+81 676648621 OSAKA-SHI, OSK  530-8552  Japan Ticker: 45364536
Business Summary
SANTEN PHARMACEUTICAL CO., LTD. is a Japan-based pharmaceutical company engaged in the research, development, manufacturing and sales of pharmaceutical products. The Company has medical pharmaceutical business, OTC drugs business, medical devices business and other businesses. The Company engages in manufacture, sale and clinical development of medical pharmaceutical products, the development, manufacturing and sales of medical equipment, as well as the cleaning business. The Company operates in Japan, Europe, Asia, North America markets.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20233/31/2023Yes---Yes

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
5047 Medical, dental, and hospital equipment and supplies
7349 Building cleaning and maintenance services, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board AkiraKurokawa 70 4/1/2024 6/1/2006
President, Chief Executive Officer, Representative Director TakeshiIto 64 9/12/2022 6/23/2017
Chief Financial Officer, Chief Risk Officer, Executive Officer KazuoKoshiji 1/1/2022 1/1/2013
12 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Novagali Pharma SA 1 rue Pierre Fontaine Genavenir IV Evry cedex France

Business Names
Business Name
4536
Novagali Pharma SA
Santen Pharmaceutical Co. Ltd.
4 additional Business Names available in full report.

General Information
Number of Employees: 4,144 (As of 3/31/2023)
Outstanding Shares: 351,204,085 (As of 3/31/2024)
Shareholders: 30,507
Stock Exchange: TYO
Fax Number: +81 663593827


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, April 28, 2024